MORRISVILLE, N.C. – July 7, 2021 – Syneos Health Communications – the portfolio of Syneos Health® agencies designed to deliver insights-driven integrated communications – has added executives to lead high-growth areas within its Public Relations Group including Biosector 2, Chamberlain Healthcare Public Relations and Chandler Chicco Agency. Hires emphasize talent and expertise in creative execution, public affairs, corporate communications, social impact and influencer marketing.

John Reid, a creative agency veteran with vast experience executing notable brand campaigns, joins as Executive Creative Director. John previously served as Chief Creative Officer at McCann Health and EVP and Chief Creative Officer at Razorfish Health. He has built an impressive portfolio that is deep-rooted in pharma and healthcare, delivering results for Procter & Gamble, Biogen, AstraZeneca, GSK, Johnson and Johnson, Merck, Regeneron and Pfizer. 

“We are excited to welcome John to the Syneos Health Communications family. The work he creates on behalf of his clients is forward-thinking, impactful and results-driven – all qualities we embody as market-leading agencies,” said Jeanine O’Kane, President, Public Relations, Syneos Health Communications. “This additional creative infusion will help evolve how we solve problems and formulate new solutions through powerful storytelling that is authentic and honest.”

In addition to boosting creative capabilities, Biosector 2, Chamberlain and Chandler Chicco Agency are doubling down on strategic, future-focused offerings within corporate communications, reputation & risk management, influencer marketing and social impact. These high-value solutions help clients prepare for and tackle the numerous challenges facing the healthcare industry today.  

To drive these important client solutions, the Public Relations Group has hired Cameron Coursen, who joins as a Senior Public Affairs Strategist on the reputation and risk management group; added Prateek Patnaik, who was brought on to drive the corporate communications practice as SVP and Senior Strategist; and promoted Sharon Gordon to SVP to lead social impact work. Fran DeSena, SVP of influencer marketing, has joined to lead the agencies’ unique approach to connect with health influencers of all types, called “type i,” which is a proprietary platform combining scientific, KOL, social media and behavioral science expertise that facilitates the identification, assessment, management and measurement of influencers for healthcare brands. Additionally, Adam Rogers and Rachael Adler have joined as team leads, with Adam focused on content development and Rachael guiding media strategy and execution. 

Biosector 2, Chamberlain Healthcare Public Relations and Chandler Chicco Agency are among the industry’s leading pure-play healthcare PR agencies. From companies looking to commercialize their first product to established pharma companies with late-stage pipeline products, clients come to Syneos Health Public Relations Group for communications programs that influence the encounters when and where health decisions are made. 

Take a deeper dive into the evolution of storytelling by listening to our latest podcast on the Syneos Health Insights Hub:

Syneos Health Communications: At the Heart of Health

Syneos Health Communications is a purpose-built portfolio of innovative health-first, health-only advertising, branding, medical communications, market access and public relations agencies. Fiercely focused on creating platforms that allow customers to bring life-changing healthcare solutions to the world, Syneos Health Communications is an unrivaled community — powered by 26,000 clinical and commercial minds across Syneos Health® — that operates at the intersection of health, technology, and creativity. In addition to Biosector 2, Chamberlain Healthcare Public Relations and Chandler Chicco Agency, the portfolio includes GSW, Spherico, Litmus, Navicor, Cadent Medical Communications and Addison Whitney.

About Syneos Health

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 26,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.

To learn more about how we are Shortening the distance from lab to life®, visit or subscribe to our podcast.

Investor Relations Contact:
Press/Media Contact:
Ronnie Speight  
Gary Gatyas
Senior Vice President, Investor Relations
Executive Director, External Communications
+1 919 745 2745
+1 908 763 3428
[email protected]
[email protected]